Полиморфизм генов, белковые продукты которых играют роль в развитии воспаления, при ишемическом инсульте

28. Оганов Р. Г. Новый способ оценки индивидуального сердечно-сосудистого суммарного риска для населения России / // Кардиология. - 2008. - № 5. - С. 87 - 91

29. Парфенов В. А. Факторы риска и профилактика ишемических цереброваскулярных заболеваний. //ММА имени И.М. Сеченова, Русский медицинский журнал. - 2002. - Том 10, - №17

30. Парфенов М.Г. Участие генов, кодирующих компоненты систем гемостаза, липидного метаболизма и ренин-ангиотензин-альдостероновой системы, в формировании предрасположенности к ишемическому инсульту у русских и якутов: автореферат дисс. канд. биол. наук: 03.00.03/ М., - 2007

31. Парфенов М.Г., Титов Б.В., СудомоинаМ.А., Мартынов М.Ю., Фаворов А.В., M.F. Ochs, Гусев Е.И., Фаворова О.О. Комплексный анализ генетической предрасположенности к ишемическому инсульту у русских // Молекулярная биология. - 2009. - Т. 43. - № 5. - С. 937 - 945

32. Сергеев П.В., Шимановский Н.Д., Петров В.И. Рецепторы. М. Волгоград, - 1999; - С. 346-423

33. Скворцова В.И., Ефремова Н.М., Шамалов Н.А. и др. Церебральная ишемия и нейропротекция. Медицина. Инсульт. - 2006. - № 13. - С. 35-42

34. Сквоpцова В.И., Сломинский П.А., Кольцова Е.А., Тупицына Т.И., Милосеpдова О.В., Боцина А.Ю., Лимбоpская С.А.: Изучение pоли миссенс-мутации (М235Т) гена ангиотензиногена в pазвитии ишемической болезни мозга. // Молекулярная генетика, микробиология и вирусология. - 2003. - №1. - С. 52-54

35. Суслина З. А., Варакин Ю. Я., Верещагин Н. В. Сосудистые заболевания головного мозга. 2-е издание. М.: МЕДпресс-информ. -2009. - С. 352

36. Суслина З. А., Танашян М. М., Ионова В. Г. Ишемический инсульт: кровь, сосудистая стенка, антитромботическая терапия. - М.: Медицинская книга, - 2005. - С. 248

37. Сухинина Т.С., Шахнович Р.М., Барсова Р.M., Матвеева Н.А., Титов Б.В., Судомоина М.А., Фаворова О.О., Руда М.Я Значение аллельного полиморфизма генов системы воспаления для прогноза больных инфарктом миокарда// Журнал "Кардиология". - 2012. - № 3. - С. 15-21

38. Тупицына Т.В., Бондаренко Е.А., Боцина А.Ю., Шетова И.М., Лимборская С.А., Скворцова В.И., Сломинский П.А. Роль полиморфных вариантов гена индуцибельной NO-синтазы NOS2 в формировании инфаркта мозга у больных с острым ишемическим инсультом // Молекулярная генетика, микробиология и вирусология. - 2010. - №3. - С. 3 - 7

39. Усачева (Авдонина) М.А., Наседкина Т.В., Иконникова А.Ю., Куликов А.В., Чудинов А.В., Лысов Ю.П., Бондаренко Е.В., Сломинский П.А., Шамалов Н.А., Шетова И.М, Лимборская С.А., Заседателев А.С., Скворцова В.И. Анализ ассоциации полиморфных маркеров генов ренин-ангиотензиновой системы и системы гемостаза с ишемическим инсультом среди русских центральной России // Молекулярная биология. - 2012, - Том 46. - №2. - С. 214-223

40. Фаворова О.О., Судомоина М.А., Мартынов М.Ю., Сердюк И.Е., Парфенов М.Г., Никонова А.А., Колесникова Т.И., Ясаманова А.Н., Гусев Е.И. Влияние полиморфизма гена b-фибриногена на показатели тромбоцитарного гемостаза и уровень фибриногена у больных ишемическим инсультом // Журнал неврологии и психиатрии имени С.С. Корсакова. Приложение «Инсульт» - Москва, -2008. - Том 108. -№ 23 - С.10-15

41. Харченко Е. П., Клименко М. Н. Иммунная уязвимость мозга // Журнал неврологии и психиатрии им. Корсакова. - 2007. - №1. - С. 68-77

42. Хаспеков Л.Г., Онуфриев М.В., Лыжин А.А., и др. Влияние ишемии на активность синтазы оксида азота в органотипической культуре ткани гиппокампа. - В кн.: Гипоксия: механизмы, адаптация, коррекция, Материалы 2-й Всеросссийской Конференции. - М. - 1999. -С. 81

43. Хенерици Дж., Богуславски Ж., Сакко Р. Л. Инсульт: клиническое руководство / под редакцией. Пер. с англ.; под общей ред. Чл.-корр. РАМН В. И. Скворцовой. М.: МЕДпресс-информ. - 2008. - С. 224

44. Acalovschi D., Wiest T., Hartmann M., Farahmi M., Mansmann U., Auffarth G.U., Grau A.J., Green F.R., GrondGinsbach C., Schwaninger M. Multiple levels of regulation of the interleukin-6 system in stroke // Stroke. - 2003. - 34, - Pp. 1864-1869

45. Adamopoulos S, Kolokathis F, Gkouziouta A, Georgiadou P, Chaidaroglou A, Karavolias GK, Degiannis D, Voudris V, Kremastinos DT. Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy // Cytokine. - 2011. - 54(1). - Pp. 68-73

46. Aihara K, Ikeda Y, Yagi S, Akaike M, Matsumoto T. Transforming Growth Factor-в1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome // Cardiol Res Pract. - 2011. - Pp. 175381

47. Akira S, Isshiki H, Nakajima T et al. Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6 // Ciba Found Symp. - 1992. - 167. - Pp. 47-62

48. Allen CL., Bayraktutan U. Risk factors for ischaemic stroke // Int J Stroke. - 2008. - № 2 Vol. 3. - Pp. 105-116

49. Alzamora MT, Sorribes M, Heras A, Vila N, Vicheto M, Forйs R, Sбnchez-Ojanguren J, Sancho A. Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study // BMC Neurol. - 2008. - № 8. - Pp 5 - 8

50. Ambrose JA, Barua RS: The pathophysiology of cigarette smoking and cardiovascular disease: an update // J Am Coll Cardiol. - 2004. - 43. - Pp. 1731-1737

51. Annes JP, Mungers JS, Rifkin DB. Making sense of latent TGF beta activation // J Cell Sci. - 2003. - 116. - 217-224

52. Antonicelli R, Olivieri F, Cavallone L et al. Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers // Coron Artery Dis. - 2005. - 16(8). - Pp. 489-93

53. Antonios N., Angiolillo DJ., Silliman S. Hypertriglyceridemia and ischemic stroke // Eur Neurol. - 2008. - Vol. 60, - № 6. - Pp. 269 - 278

54. Arenillas JF, Massot A, Alvarez-Sabнn J, Fernandez-Cadenas I, del Rio-Espinola A, Chacon P, Quintana M, Molina CA, Rovira A, Montaner J. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses // Cerebrovasc Dis. - 2009. - 28(1). - Pp. 95-102

55. Ariyaratnam R., Casas J.P., Whittaker J., Smeeth L., Hingorani A.D. and Sharma P. (2007) Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals // PLoS Med. - 4, - e131

56. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, Hutchinson IV TGF-beta (1) genotype and accelerated decline in lung function of patients with cystic fibrosis // Thorax. - 2000. - 55. - Pp. 459- 462

57. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation // Transplantation. - 1998. - 66. - Pp.1014- 1020

58. Azzawi M, Hasleton P. Tumour necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease // Cardiovasc Res. - 1999. - 43. - Pp.850-9

59. Balding J., Livingstone W.J., Pittock S.J., Mynett Johnson L., Ahern T., Hodgson A., Smith O.P. The IL-6 G174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension // Irish J. Med. Sci. - 2004. - 4. - Pp. 200-203

60. Banerjee I, Gupta V, Ahmed T, Faizaan M, Puneet A, Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: A case-control study in an Indian population // BrainResBull. - 2008. - 75. - Pp.158-65

61. Bang O.Y. Possible mechanisms and controversies of protective effects of risk factors against stroke severity // J Neurol Sci. - 2008. - 267. -Pp. 188-189

62. Barna, B.P., Estes, M.L., Pettay, J., Iwasaki, K., Zhou, P. &Barnett, G.H. Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression // Journal of Neuroimmunology. - 1995. - Pp. 60, 75

63. Baum L, Ng HK, Wong KS, Tomlinson B, Rainer TH, Chen X, Cheung WS, Tang J, Tam WW, Goggins W, Tong CS, Chan DK, Thomas GN, Chook P, Woo KS. Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction // Clin Chem Lab Med. - 2006. - Vol. 44, -№ 3. - Pp. 274-281

64. Baum L, Wong KS, Ng HK, Tomlinson B, Rainer TH, Chan DK, Thomas GN, Chen X, Poon P, Cheung WS, Woo KS. Methylenetetrahydrofolate reductase gene A222V polymorphism and risk of ischemic stroke // Clin Chem Lab Med. - 2004. -Vol. 42, № 12. - Pp. 1370 - 1376

65. Bejot Y. Stroke in the very old: incidence, risk factor, clinical features, outcomes and access to resources - a 22-year population based study // Cerebrovasc. Dis. - 2010. - 29. - Pp. 111--121

66. Bennet AM, Di Angelantonio E, Ye Z et al: Association of apolipoprotein E genotypes with lipid levels and coronary risk // JAMA. - 2007. - 298. - Pp. 1300- 1311

67. Benowitz NL: Cigarette smoking and cardiovascular disease:pathophysiology and implications for treatment // Prog CardiovascDis. - 2003. - 46. - Pp. 91-111

68. Benveniste E.N. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action // Am J Physiol. - 1992. - 263. - Pp. 1-16

69. Bersano A., Ballabio E., Bresolin N. et al. Genetic polymorphisms for the study of multifactorial stroke //Hum. Mutat. - 2008. - V. 29. № 6. - Pp. 776-795

70. Bevan, S., Dichgans, M., Gschwendtner, A., KuhlenbaЁumer, G., Ringelstein, E.B. and Markus, H.S. Variation in the PDE4D gene and ischemic stroke risk. A systematic review and meta-analysis on 5200 cases and 6600 controls // Stroke. -2008. - P.39

71. Bevan S., Markus H. The genetics of stroke // ACNR. - 2004. - V. 4. № 4. - Pp. 9-11

72. Bevan S., Porteous L., Sitzer M., Markus H. S. Phosphodiesterase 4D gene, ischemic stroke and asymptomic carotid atherosclerosis // Stroke. - 2005. - 36. - Pp. 949--953

73. Bhat V.M., Cole J.W., Sorkin J.D., Wozniak M.A., Malarcher A.M., Giles W.H., Stern B.J., Kittner S.J. Dose-response relationship between cigarette smoking and risk of ischemic stroke in young women // Stroke. - 2008. - 39(9). - Pp. 2439-43

74. Bin Wanga, Hongye Zhaoa, Li Zhou, Xiaoxi Daic, Dayu Wang, Jun Cao, Wenquan Niu. Association of genetic variation in apolipoprotein E and low density lipoprotein receptor with ischemic stroke in Northern Han Chinese // Journal of the Neurological Sciences. - 2009. - V. 276, Issues 1-2. - Pp. 118-122

75. Biswas A., Ranjan R., Meena A., Akhter M.S., Yadav B.K., Munisamy M., Subbiah V., Behari M., Saxena R. Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian Indians // J Stroke Cerebrovasc Dis. - 2009. - 18. - Pp. 103-110

76. Blobe G.C., Schiemann W.P., Lodish H.F. Role of transforming growth factor beta in human disease // N Engl J Med. - 2000. - 342. - Pp. 1350-7

77. Bonilla F.A., Bernstein I.L., Khan D.A., Ballas Z.K., Chinen J., Frank M.M., Kobrynski L.J., Levinson A.I., Mazer B., Nelson R.P. Jr, Orange J.S., Routes J.M., Shearer W.T., Sorensen R.U. Practice parameter for the diagnosis and management of primary immunodeficiency // Ann Allergy Asthma Immunol. - 2005. -94 (5 Suppl 1). - Pp. 1-63,

78. Bonita R., Beaglehole R., Asplund K. The worldwide problem of stroke // Curr Opin Neurol. - 1994. - 7(1). - Pp. 5-10

79. Bonita R., Broad J.B., Beaglehole R. Ethnic Difference in Stroke Incidence and Case Fatality in Aukland, New Zeland // Stroke. - 1997. - Vol. 28, № 4. - Pp. 758 - 761

80. Bowcock A. M.; Kidd, J. R.; Lathrop, G. M. et al. The human 'interferon-beta-2/hepatocyte stimulating factor/interleukin-6' gene: DNA polymorphism studies and localization to chromosome 7p21 // Genomics. - 1988. - 3. -Pp. 8-16

81. Bowman T. S. et al. Cholesterol and the risk of ischemic stroke // Stroke. - 2003. - Vol. 12, № 34. - Pp. 2930 - 2934

82. Brass LM, Alberts MJ.: The genetics of cerebrovascular disease. //Baillieres Clin Neurol. - 1995. Aug;4(2). - Pp. 221-45

83. Brenneman DE, Schultzberg M, Bartfai T, Gozes I. Cytokine regulation of neuronal survival // J Neurochem. - 1992. Feb;58(2). - Pp. 454-60

84. Brophy V.H., Ro S.K., Rhees B.K. et al. Association of phosphodiesterase 4D polymorphism with ischaemic stroke in a US population stratified by hypertension status // Stroke. - 2006. - 37. - Pp. 1385--1390

85. Brouwer D.A., van Doormaal J.J., Muskiet F.A.: Clinical chemistry of common apolipoprotein E isoforms.// J Chromatogr B Biomed Appl. - 1996. Mar 29; 678(1). -Pp. 23-41

86. Browning, J.L., Ngam-ek, A., Lawton, P., et.al. Lymphotoxin beta, a novel member of the TNF family that forms a heterodimeric complex with lymphotoxin on the cell surface // Cell. - 1993. - 72. - Pp. 847-856

87. Bullido M.J, Valdivieso F. Apolipoprotein E gene promoter polymorphisms in Alzheimer?disease // Micros Res Techn. - 2000. - № 50. - Pp. 261 - 267

88. Buraczynska K, Luchowski P, Wojczal J, Ksiazek A, Stelmasiak Z. Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities // Clin Biochem. - 2010. Dec;43(18). - Pp. 1421-6

89. Carpentier P.A., Duncan D.S., Miller S.D. Glial Toll-like Receptor Signaling in Central Nervous System Infection and Autoimmunity // Brain Behav Immun. - 2008. 22(2). - Pp. 140-147

90. Carty C.L., Heagerty P., Heckbert S.R., Jarvik G.P., Lange L.A., Cushman M., Tracy R.P., Reiner A.P. Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study // Ann Hum Genet. - 2010. - 74. - Pp. 1-10

91. Casas, J.P., Hingorani, A.D., Bautista, L.E. and Sharma, P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls // Arch. Neurol. - 2004. - 61. - Pp.1652-1661

92. Cavet J., Dickinson A. M., Norden J., Taylor P. R., Jackson G. H., and Middleton P. G., Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation // Blood. - 2001. - 98(5). - Pp. 1594-600

93. Chamorro A., Revilla M., Obach V., Vargas M., Planas A.M. The -174G/C polymorphism of the interleukin 6 gene is a hallmark of lacunar stroke and not other ischemic stroke phenotypes // Cerebrovascular Diseases. - 2005. - 19. - Pp. 91?95

94. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors // Brain Behav Immun. - 1995. - 9. - Pp. 355-365

95. Chao, C.C., Molitor, T.W. & Hu, S. Neuroprotective role of IL-4 against activated microglia // Journal of Immunology. - 1993. - 151. - P. 1473

96. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins // Growth Factors. - 2004. - V.22 №4. - Рp.233-41

97. Chen W., Jin W., Wahl S.M. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells // J Exp Med. - 1998. - V.188 №10. - Рp.1849-57

98. Chen X.C., Xu M.T., Zhou W., Han C.L., Chen W.Q. A meta-analysis of beta-fibrinogen gene -455G/A polymorphism and plasma fibrinogen level in Chinese cerebral infarction patients // Biomed Environ Sci. - 2007. - 20. - Pp. 366?372

99. Chen X.C., Xu M.T., Zhou W., Han C.L., Chen W.Q. A meta-analysis of relationship between в-fibrinogen gene -148C/T polymorphism and susceptibility to cerebral infarction in Han Chinese // Chin Med J (Engl). - 2007. - 120. - Pp.1198-1202

100. Cheng J., Liu J., Li X., Yu L., Peng J., Zhang R., Geng Y., Nie S. Effect of polymorphisms of endothelial nitric oxide synthase on ischemic stroke: a case-control study in a Chinese population // Clin Chim Acta. - 2008. Jun;392(1-2). - Pp. 46-51

101. Chomarat, P., Vannier, E., Dechanet, J., Rissoan, M. C., Banchereau, J., Dinarello, C. A., et al. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10 // Journal of Immunology. - 1995. - 154. - Pp. 1432-1439

102. Cole JW, Brown DW, Giles WH, Stine OC, O'Connell JR, Mitchell BD, Sorkin JD, Wozniak MA, Stern BJ, Sparks MJ, Dobbins MT, Shoffner LT, Zappala NK, Reinhart LJ, Kittner SJ. Ischemic stroke risk, smoking, and the genetics of inflammation in a biracial population: the stroke prevention in young women study // Thromb J. - 2008. Aug 26. - Pp. 6-11

103. Conley E.C. The Ion Channel Facts Book: Extracellular Ligand-Gated Channels // Cell Calcium. - 1996. - Vol. 11. - Pp. 233-239

104. Corella D., Guillen M., Saiz C. et al. Environmental factors modulate the effect of the APOE genetic polymorphism on plasma lipid concentrations: ecogenetic studies in a Mediterranean Spanish population // Metabolism. -- 2001. -- 50, № 8. -- Pp. 936-944

105. Crisan D., Carr J. Angiotensin I-Converting Enzyme. Genotype and Disease Associations // JMD. -2000. -Vol. 2, № 3. P. 105

106. Crobu F, Palumbo L, Franco E, Bergerone S, Carturan S, Guarrera S, Frea S, Trevi G, Piazza A, Matullo G. Role of TGF-beta1 haplotypes in the occurrence of myocardial infarction in young Italian patients // BMC Med Genet. - 2008. - Feb 29. - 9 P. 13

107. Dalziel B, Gosby A, Richman R, Bryson J, Caterson I. Association of the TNF-б (?308 G/A) promoter polymorphism with insulin resistance in obesity // Obes Res. -2002. - 10(5). - Pp.401-407

108. Dayer J.M., Choy E. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor // Rheumatology (Oxford). - 2010. - 49(1). - Pp. 15-24

109. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies // Nat Genet. - 2005. -Nov; 37(11). - Pp.1217-23

110. Dichgans, M. Genetics of ischaemic stroke // Lancet Neurol. - 2007. -6. - Pp. 149-161

111. Domingues-Montanari S, Fernandez-Cadenas I, del Rio-Espinola A, Mendioroz M, Ribo M, Obach V, Marti-Fabregas J, Freijo M, Serena J, Corbeto N, Chacon P, Alvarez-Sabin J, Montaner J. The I/D polymorphism of the ACE1 gene is not associated with ischemic stroke in Spanish individuals // Eur J Neurol. - 2010. - Nov;17(11). - Pp. 1390-1392

112. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke // Lancet. - 2008. -10. - Pp. 1612-1623

113. Donner H., H. Rau P. G., Walfish J. Braun, T. Siegmund R. Finke, J. Herwi, K. H. Usadel K. Badenhoop. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus // J. Clin. Endocrinol. Metab. - 1997. - 82. - Pp. 143

114. Duan H, Cai Y, Sun X. Platelet glycoprotein IIb/IIIa polymorphism HPA-3 b/b is associated with increased risk of ischemic stroke in patients under 60 years of age // Med Sci Monit. - 2012. - Jan;18(1). - Pp. 19-24

115. Duan H.O., Simpson-Haidaris P.J. Functional analysis of interleukin 6 response elements (IL-6REs) on the human gamma-fibrinogen promoter: binding of hepatic Stat3 correlates negatively with transactivation potential of type II IL-6Res // J Biol Chem. - 2003. - 278. - Pp. 41270-41281

116. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer // Cancer Res. - 2003. - May 15;63(10). - Pp. 2610-2615

117. Dziedzic T, Slowik A, Pera J, Szczudlik A.: Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease. // Cerebrovasc Dis. - 2005. - 20(5). - Pp. 299-303

118. El-Gamel A, Awad M, Sim E, Hasleton P, Yonan N, Egan J, Deiraniya A, Hutchinson IV. Transforming growth factor-beta1 and lung allograft fibrosis // Eur. J. Cardiothorac. Surg. - 1998. - 13. - Pp. 424- 430

119. Ellerby L.M., Ellerby H.M., Park S.M. et al. Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2 // J Neurochem. - 1996. - 67. - Pp. 1259-1267

120. Engel M.E., Datta P.K., Moses H.L. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation // J Cell Biochem Suppl. - 1998. - V.30-31. - Рp.111-122

121. Etokebe GE, Bulat-Kardum L, Johansen MS, Knezevic J, Balen S, Matakovic-Mileusnic N, Matanic D, Flego V, Pavelic J, Beg-Zec Z, Dembic Z. Interferon-gamma gene (T874A and G2109A) polymorphisms are associated with microscopy-positive tuberculosis // Scand J Immunol. - 2006. - Feb;63(2). - Pp. 136-41

122. Favorov A.V., Andreewski T.V., Sudomoina M.A., Favorova O.O., Parmigiani G., Ochs M.F. A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans // Genetics. - 2005. - Dec;171(4). - Pp. 2113-21

123. Favorova O.O., Favorov A.V., Boiko A.N., Andreewski T.V., Sudomoina M.A., Alekseenkov A.D., Kulakova O.G., Gusev E.I., Parmigiani G., Ochs M.F. Three allele combinations associated with multiple sclerosis // BMC Med Genet. - 2006. - Jul 26;7. - P. 63

124. Ferrari J, Rieger S, Endler G, Greisenegger S, Funk M, Scholze T, Lang W, Lalouschek W, Mannhalter C.: The Thr715Pro polymorphism of the P-selectin gene is not associated with ischemic stroke risk // Stroke. - 2007. - Feb; 38(2). - Pp. 395-7

125. Ferrucci L., Guralnik J.M., Pahor M., Harris T., Corti M.C., Hyman B.T., Wallace R.B., Havlik R.J.: Apolipoprotein E epsilon 2 allele and risk of stroke in the older population.// Stroke. - 1997. Dec;28(12). - Pp. 2410-2416

126. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis // J Clin Invest. - 1998. - Oct 1;102(7). - Pp.1369-1376

127. Flex A., Gaetani E., Papaleo P., Straface G., Proia A.S., Pecorini G., Tondi P., Pola P., Pola R. Proinflammatory genetic profiles in subjects with history of ischemic stroke // Stroke. - 2004. - Oct;35(10). - Pp. 2270-2275

128. Flossmann E., Rothwell P.M. Family history of stroke in patients with transient ischemic attack in relation to hypertension and other intermediate phenotypes. // Stroke. - 2005. - Apr;36(4). - Pp. 830-835

129. Flossmann E., Rothwell P.M. Family history of stroke does not predict risk of stroke after transient ischemic attack. // Stroke. - 2006. - Feb;37(2). - Pp. 544-546

130. Flossmann E., Schulz U.G., Rothwell P.M. A systematic review of the methods and results of studies of the genetic epidemiology of ischaemic stroke // Stroke. - 2004. - 35. - Pp.212-227

131. Flossmann E., Schulz U.G., Rothwell P.M. Potential confounding by intermediate phenotypes in studies of the genetics of ischaemic stroke. // Cerebrovasc Dis. - 2005 .19(1). - Pp. 1-10

132. Folcik VA, Smith T, O'Bryant S, Kawczak JA, Zhu B, Sakurai H, Kajiwara A, Staddon JM, Glabinski A, Chernosky AL, Tani M, Johnson JM, Tuohy VK, Rubin LL, Ransohoff RM. Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors // J Neuroimmunol. - 1999. - Jun 1;97(1-2). - Pp. 119-28

133. Folkert W., Jennifer K., Kathryn M.et al. Effects of lymphotoxin-б gene and galectin-2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules and risk of coronary heart disease // Clinical Science. - 2007. - 112. - Pp. 291-298

134. Fornage M. Genetics of stroke // Curr Atheroscler Rep. - 2009. - 11; 3. - Pp. 167-174

135. Fornage M, Debette S, Bis JC, Schmidt H, Ikram MA, Dufouil C, Sigurdsson S, Lumley T, DeStefano AL, Fazekas F, Vrooman HA, Shibata DK, Maillard P, Zijdenbos A, Smith AV, Gudnason H, de Boer R, Cushman M, Mazoyer B, Heiss G, Vernooij MW, Enzinger C, Glazer NL, Beiser A, Knopman DS, Cavalieri M, Niessen WJ, Harris TB, Petrovic K, Lopez OL, Au R, Lambert JC, Hofman A, Gottesman RF, Garcia M, Heckbert SR, Atwood LD, Catellier DJ, Uitterlinden AG, Yang Q, Smith NL, Aspelund T, Romero JR, Rice K, Taylor KD, Nalls MA, Rotter JI, Sharrett R, van Duijn CM, Amouyel P, Wolf PA, Gudnason V, van der Lugt A, Boerwinkle E, Psaty BM, Seshadri S, Tzourio C, Breteler MM, Mosley TH, Schmidt R, Longstreth WT, DeCarli C, Launer LJ. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium // Ann Neurol. - 2011. - Jun;69(6). - Pp. 928-939

136. Freilinger T, Bevan S, Ripke S, Gschwendtner A, Lichtner P, Mьller-Myhsok B, Wichmann HE, Markus HS, Meitinger T, Dichgans M. Genetic variation in the lymphotoxin-alpha pathway and the risk of ischemic stroke in European populations // Stroke. - 2009. - Mar;40(3). - Pp. 970-2

137. Frigerio S., Gelati M., Ciusani E., Corsini E., Dufour A., Massa G., Salmaggi A. Immunocompetence of human microvascular brain endothelial cells: cytokine regulation of IL-1beta, MCP-1, IL-10, sICAM-1 and sVCAM-1 // J Neurol. - 1998. - V.245 №11. - Рp.727-30

138. Frossard P.M., Malloy M.J., Lestringant G.G., Kane J.P.: Haplotypes of the human renin gene associated with essential hypertension and stroke.// Hum Hypertens. - 2001. - Jan;15(1). - Pp. 49-55

139. Frosst P, Blom HJ, Milos R,Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylentetrahydrofolate reductase // Nat Genet. - 1995. - 10. - Pp. 111-113

140. Fukumoto S., Koyama H., Hosoi M. et al. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin dependent kinase 4 activation // Circ. Res. - 1999. - V. 85. № 11. - Pp. 985-991

141. Fuller G.M., Zhang Z. Transcriptional control mechanism of fibrinogen gene expression // Ann N Y Acad Sci. - 2001. - 936. - Pp. 469-447

142. Gangwar R., Pandey S., Mittal R.D. Association of interferon-г+874A polymorphism with the risk of developing cervical cancer in north-Indian population // BJOG. 2009. - 116. - Pp. 1671-1677

143. Gao J, Sun YF, Li YL, Su LK, Guo L. Hyperhomocysteine, genetic polymorphism of methylenetetra-hydrofolate reductase in young adults with ischemic stroke // J Zhengzhou Univ Med Sci. - 2008. - 43. - Pp. 570-573

144. Gonzбlez Hernбndez A. et al. Risk factors, etiology and prognosis in patients with ischemic stroke and diabetes mellitus // Rev Clin Esp. - 2008. - Vol. 208, № 11. - Pp. 546 - 550

145. Goracy I, Cyryіowski L, Kaczmarczyk M, Fabian A, Koziarska D, Goracy J, Ciechanowicz A. C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects // J Appl Genet. - 2009. - 50. - Pp. 63-67

146. Gormley K, Bevan S, Markus HS.: Polymorphisms in genes of the renin-angiotensin system and cerebral small vessel disease. // Cerebrovasc Dis. - 2007. - 23(2-3). - Pp. 148-55

147. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-Я is inhibited in transgenic apolipoprotein(a) mice // Nature. - 1994. - 370. - Pp. 460-462

148. Greisenegger S, Endler G, Haering D, Schillinger M, Lang W, Lalouschek W, et al. The (174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events // Thromb Res. - 2003. - 110. - Pp. 181-6

149. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke // Nat Genet. - 2003. - 35. - Pp. 131-138

150. Gretarsdottir, S., Thorleifsson, G., Manolescu, A., Styrkarsdottir, U.Helgadottir, A., Gschwendtner, A., Kostulas, K., KuhlenbaЁumer, G., Bevan, S., Jonsdottir, T. et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke // Ann. Neurol. -2008. - 64. - Pp. 402-409

151. Gschwendtner A., Bevan S., Cole J. W. et al., Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke // Annals of Neurology. - 2009. - vol. 65, №. 5. - Pp. 531-539

152. Gudbjartsson, D.F.,Holm, H.,Gretarsdottir, S., Thorleifsson,G.,Walters, G.B., Thorgeirsson, G., Gulcher, J., Mathiesen, E.B., Njшlstad, I., Nyrnes, A. et al. Asequence variant inZFHX3on 16q22 associateswith atrial fibrillation and ischemic stroke // Nat. Genet. - 2009. - 41. - Pp. 876-878

153. Guldiken B., Guldiken S., Turgut B. et al. The roles of oxidized low-density lipoprotein and interleukin-6 levels in acute atherothrombotic and lacunar ischemic stroke // Angiology.- 2008.- Vol.59, №2.- Pp.224-229

154. Haddad M., Rhinn H., Bloquel C., B. Coqueran, C. Szabo, M. Plotkine, D. Scherman, I. Margaill. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice // Br. J. Pharmacol. - 2006. - 149. - Pp. 23-30

155. Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M. Polymorphisms in the lymphotoxin alpha gene and the risk of ischemic stroke in the Japanese population. The Fukuoka Stroke Registry and the Hisayama Study // Cerebrovasc Dis. - 2008. - 25(5). - Pp. 417-22

156. Hakonarson H. Role of FLAP and PDE4D in myocardial infarction and stroke: target discovery and future treatment options // Curr. Treat. Options Cardiovasc. Med. - 2006. - V. 8. № 3. - Pp. 183-192

157. Halliwell B.L. Packer L., Prilipko Y. Free Radicals in the Brain // Aging, Neurological and Mental Disorders (Christen Y. ed). Berlin. - 1992. - Pp. 21-40

158. Hansson GK, Robertson AK, Sцderberg-Nauclйr C. Inflammation and atherosclerosis.// Annu Rev Pathol. - 2006. - Pp.297-329

159. Harbuzova VIu, Matlai O.I., Ataman Iu.O., Dubovyk Ie.I, Borodenko A.O., Obukhova O.A., Ataman O.V. The polymorphism of matrix Gla-protein gene in ischemic atherothrombotic stroke patients // Fiziol Zh. - 2012. - 58(5). - Pp. 14-21

160. Harcos P, Laki J, Kiszel P, Szйplaki Z, Szolnoki Z, Kovбcs M, Melegh B, Szйplaki G, Fьst G, Blaskу B. Decreased frequency of the TNF2 allele of TNF-alpha -308 promoter polymorphism is associated with lacunar infarction // Cytokine. - 2006. - Jan 21;33(2). - Pp. 100-5

161. Hassan A, Gormley K, O'Sullivan M, Knight J, Sham P, Vallance P, Bamford J, Markus H. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease // Stroke. - 2004. - Mar;35(3). - Pp. 654-659

162. Hassan A. and Markus H. S. Genetics and ischaemic stroke // Brain. - 2000. - vol. 123, №. 9. - Pp. 1784-1812

163. Heinrich P.C., Behrmann I., Haan S. et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation // Biochem J. - 2003. - 15(374). - Pp. 1-20

164. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response // Biochem J. - 1990. - 265. - Pp. 621-636

165. Heldin C-H., Miyazono K. & Dijke P.ten TGF-b signalling from cell membrane to nucleus through SMAD proteins // Nature. - 1997. - 390. - Pp. 465-471

166. Helgadottir, A., Manolescu, A., Thorleifsson, G., Gretarsdottir, S.,Jonsdottir, H., Thorsteinsdottir, U., Samani, N.J., Gudmundsson, G.,Grant, S.F., Thorgeirsson, G. et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke // Nat. Genet. - 2004. - 36. - Pp. 233-239

167. He Y, Bai JY, Song B, Tan S, Chang YS, Li T, Shi CC, Zhang H, Feng QC, Qi H, Song GY, Zheng H, Xu YM. Sex-dependent association of phosphodiesterase 4D gene polymorphisms with ischemic stroke in Henan Han population // Chin Med J (Engl). - 2012. - Jul;125(13). - Pp. 2255-2259

168. He Y, Lam TH, Jiang B, Wang J, Sai X, Fan L, Li X, Qin Y, Hu FB. Passive smoking and risk of peripheral arterial disease and ischemic stroke in Chinese women who never smoked // Circulation. - 2008. - Oct 7;118(15). - Pp. 1535-1540

169. He Z., Crook J.-E., Meschia J.-F., Brott T.-G., Dickson D.-W., and Mickinney M. Aging Blunts Ischemic-Preconditioning-Induced Neuroprotection Following Transient Global Ischemia in Rats // Curr. Neurovasc. Res. - 2005. - 2. - Pp.365?374

170. He Z, He B, Behrle BL, Fejleh MP, Cui L, Paule MG, Greenfield LJ. Ischemia-Induced Increase in Microvascular Phosphodiesterase 4D Expression in Rat Hippocampus Associated with Blood Brain Barrier Permeability: Effect of Age // ACS Chem Neurosci. - 2012. - Jun 20;3(6). - Pp. 428-32

171. He Z., Meschia J.-F., Brott T.-G., Dickson D.-W., and Mickinney M. Aging is Neuroprotective during Global Ischemia but Leads to Increased Caspase-3 and Apoptotic Activity in Hippocampal Neurons // Curr. Neurovasc. Res. - 2006. - 3. - Pp. 181?186

172. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M.,Mehta J.P., Collins F.S., Manolio T.A. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits // Proc. Natl. Acad. Sci.USA. - 2009. - V. 106. - Pp. 9362-9367

173. Hoffmeister H.M., Kozmaier S. Activation of inflammatory pathways in acute coronary syndromes // Europ. Heart J. - 2000. - Vol. 21. - Pp. 650-656

174. Horenstein R., Smith D., Mosca L. Cholesterol predicts stroke mortality in the women's pooling project // Stroke. - 2002. - 33, - Pp. 1863-1868

175. Hotamisligil G. Inflammation and metabolic disorders // Nature. - 2006. - 444(14). - Pp. 860-867

176. Hou L, Osei-Hyiaman D, Yu H, Ren Z, Zhang Z, Wang B, Harada S. Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients // Neurology. - 2001. - Feb 27;56(4). - Pp. 490-6

177. Houslay M.D., Adams D.R. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signaling cross-talk, desensitization and compartmentalization //Biochem. J. - 2003. - V. 370. - Pp. 1-18

178. Howard TD, Giles WH, Xu J, Wozniak MA, Malarcher AM, Lange LA, Macko RF, Basehore MJ, Meyers DA, Cole JW, Kittner SJ. Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women // Stroke. - 2005. - Sep;36(9). - Pp. 1848-1851

179. Huang W., Chen Q.W., Lei H., Deng W, Ke DZ. Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease // Zhonghua Xin Xue Guan Bing Za Zhi. - 2006. - Aug;34(8). - Pp. 718-21

180. Hunt P.J., Marshall S.E., Weetman A.P., Bell J.I., Wass J.A., Welsh K.I. Cytokine gene polymorphisms in autoimmune thyroid disease // J Clin Endocrinol Metab. - 2000. - V.85 №5. - Рp.1984-1988

181. Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D'Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB; IGIGI Investigators. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro // Arterioscler Thromb Vasc Biol. - 2005. - Jan;25(1). - Pp. 222-227

182. Ianni M, Callegari S, Rizzo A, Pastori P, Moruzzi P, Corradi D, Porcellini E, Campo G, Ferrari R, Ferrario MM, Bitonte S, Carbone I, Licastro F. Pro-inflammatory genetic profile and familiarity of acute myocardial infarction // Immun Ageing. - 2012. - Jun 24;9(1). - P. 14

183. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix // J Biol Chem. - 1986. - 261. - Pp. 4337-4345

184. Ikeda K, Nara Y, Matumoto C, Mashimo T, Tamada T, Sawamura M, Nabika T, Yamori Y.: The region responsible for stroke on chromosome 4 in the stroke-prone spontaneously hypertensive rat. // Biochem Biophys Res Commun. - 1996. - Dec 13;229(2). - Pp. 658-62

185. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, Debette S, Lumley T, Folsom AR, van den Herik EG, Bos MJ, Beiser A, Cushman M, Launer LJ, Shahar E, Struchalin M, Du Y, Glazer NL, Rosamond WD, Rivadeneira F, Kelly-Hayes M, Lopez OL, Coresh J, Hofman A, DeCarli C, Heckbert SR, Koudstaal PJ, Yang Q, Smith NL, Kase CS, Rice K, Haritunians T, Roks G, de Kort PL, Taylor KD, de Lau LM, Oostra BA, Uitterlinden AG, Rotter JI, Boerwinkle E, Psaty BM, Mosley TH, van Duijn CM, Breteler MM, Longstreth WT Jr, Wolf PA. Genomewide association studies of stroke // N Engl J Med. - 2009. - Apr 23;360(17). - Pp. 1718-1728

186. Illig T, Bongardt F, Schцpfer et al. Kooperative Gesundheitsforschung im Raum Augsburg/Cooperative Research in the Region of Augsburg. Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes // J Clin Endocrinol Metab. - 2004 Oct;89(10). - Pp. 5053-5058

187. Indolfi C., Di Lorenzo E., Rapacciuolo A. et al. 8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo // J. Am. Coll. Cardiol. - 2000. - V. 36. № 1. - Pp. 288-293

188. Ishikawa E, Ibayashi S. Blood pressure lowering therapy for mild hypertensive patients with a history of stroke // Nippon Rinsho. - 2008. - Vol. 66, № 8. - Pp. 1560 - 1565

189. Jacob C., Martin Chouly C., Lagente V. Type 4 phosphodiesterasedependent pathways: Role in inflammatory processes // Therapie. - 2002. - V. 57. № 2. - Pp. 163-168

190. Jansen M, Dannhardt G. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.// Eur J Med Chem. - 2003. - v.38. - Pp. 661-670

191. Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, Gauguier D, et al. Sensitivity to cerebral ischemic insult in a rat model of stroke is determined by a single genetic locus // Nat Genet. - 1997. - 16. - Pp. 364-7

192. Jenny N.S., Tracy R.P., Ogg M.S., Luong le A., Kuller L.H., Arnold A.M., Sharrett A.R., Humphries S.E. In the elderly, interleukin6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease // Arterioscler. Thromb. Vasc. Biol. - 2002. - 22. - Pp. 2066-2071

193. Jongeneel C. V.; Briant L.; Udalova I. A. et al. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes // Proc. Nat. Acad. Sci. - 1991. - 88. - Pp. 9717-9721

194. Jovanoviж D. R.Etiology of ischemic stroke among young adults of Serbia // Vojnosanit Pregl. - 2008. - Vol. 65, № 11. - Pp. 803 - 809

195. Kamali-Sarvestani E., Merat A., Talei A.R. Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer // Cancer Lett. - 2005. - 223. - Pp. 113-119

196. Karahan ZC, Deda G, Sipahi T, et al. TNF-alpha -308G/A and IL-6 -174 G/C polymorphisms in the Turkish pediatric stroke patients // Thromb Res. - 2005. - 1155. - Pp. 393 -398

197. Katsuno, M., Yokota, H., Yamamoto, Y. & Teramoto, A. Increased regional interleukin-4 during the acute stage of severe intracranial disorders // Neurologia Medico-Chirurgica. - 2006. - 46. - Pp. 47

198. Kavvoura F. K., Akamizu T., Awata T., Ban Y., Chistiakov D. A., Frydecka I., Ghaderi A., Gough S. C., Hiromatsu Y., Ploski R., Wang P. W., Bednarczuk T., Chistiakova E. I., Chojm M., Heward J. M., Hiratani H., Juo S. H., Karabon L., Katayama S., Kurihara S., Liu R. T., Miyake I., Omrani G. H., Pawlak E., Taniyama M., Tozaki T., and Ioannidis J. P. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis // J Clin Endocrinol Metab. - 2007. - 92(8). - Pp. 3162-3170

199. Khealani BA, Wasay M. The burden of stroke in Pakistan // Int J Stroke. - 2008. - Vol. 3, № 4. - Pp. 293 - 296

200. Khalangot M. et al. Gender Risk of Nonfatal Stroke in Type 2 Diabetic Patients Differs Depending on the Type of Treatment // J Womens Health. - 2008. - Pp. 23

201. Kiechl S., Reindl M., Wiedermann C.J. et al. Toll-like receptor 4 polymorphisms and atherogenesis // N Engl J Med. - 2002. - 347. - Pp. 185-192

202. Kim IY, Kim MM, Kim SJ. Transforming growth factor-beta : biology and clinical relevance // J Biochem Mol Biol. - 2005. - Jan 31;38(1). - Pp. 1-8

203. Kim JS. Cytokines and adhesion molecules in stroke and related diseases // J Neurol Sci. - 1996. - May;137(2). - Pp. 69-78

204. Kim MK, Kim JT, Choi SM, Lee SH, Park MS, Cho KH. Phosphodiesterase 4D gene and risk of noncardiogenic ischemic stroke in a Korean population // J Korean Med Sci. - 2009. - Apr;24(2). - Pp. 307-10

205. Kim OJ, Lee JH, Choi JK, Oh SH, Hong SH, Oh D, Kim NK. Association between tumor necrosis factor-alpha (-308G>A and -238G>A) polymorphisms and homocysteine levels in patients with ischemic strokes and silent brain infarctions // Cerebrovasc Dis. - 2010;30(5). - Pp. 483-90

206. Koenig W; Khuseyinova N. Biomarkers of Atherosclerotic Plaque Instability and Rupture // Arteriosclerosis, Thrombosis, and Vascular Biology. - 2007. - 27. - P.15

207. Kohsaka S., Volcik K., Folsom A.et al. Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G -765C polymorphism in African-Americans: The Atherosclerosis Risk in Communities Study // Atherosclerosis. - 2008. - 196. - Pp. 926-930

208. Kokubo Y., Chowdhury A.H., Date C., Yokoyama T., Sobue H., Tanaka H.: Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population.// Stroke. - 2000. - Jun;31(6). - Pp. 1299-306

209. Kokubo Y, Tomoike H, Tanaka C, Banno M, Okuda T, Inamoto N, Kamide K, Kawano Y, Miyata T. 13. Association of sixty-one non-synonymous polymorphisms in forty-one hypertension candidate genes with blood pressure variation and hypertension // Hypertens Res. - 2006. - Aug;29(8). - Pp. 611-9

210. Kouki T., Y. Sawai C. Gardine M.-E. Fisfalen M.-L. Alegre L. J. DeGroot. 2000. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease // J. Immunol. - 165:6606

211. Kouwenhoven M., Carlstrom C., Ozenci V., Link H. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke // J Clin Immunol. - 2001. - Pp. 365-375

212. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS // Trends Neurosci. - 1996. - V.19 №8. - Рp.312-8

213. Kristiansen OP, Nolsшe RL, Larsen L et al. Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females // Hum Mol Genet. - 2003. - May 153;12(10). - Pp. 1101-10

214. Kuhlenbдumer G, Berger K, Huge A, Lange E, Kessler C, John U, Funke H, Nabavi DG, Stцgbauer F, Ringelstein EB, Stoll M. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort // J Neurol Neurosurg Psychiatry. - 2006. - Apr;77(4). - Pp. 521-4

215. Kurth T. et al. Lipid levels and the risk of ischemic stroke in women // In: Neurology. - 2007. - 68. - Pp. 556-562

216. Labreuche J., Touboul P. J., Amarenco P. Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: A systematic review of the epidemiological studies // Atherosclerosis. - 2008. - № 10

217. Lafon M., Megret F., Lafage M. The innate immune facet of brain // Journal of Molecular Neuroscience. - 2006. - 29(3). - Pp. 185-194

218. Lai J, Zhou D, Xia S, Shang Y, Zhu J, Pan J, Hua B, Zhu Y, Cui L. Association of interleukin-1 gene cluster polymorphisms with ischemic stroke in a Chinese population // Neurol India. - 2006. - Dec;54(4). - Pp. 366-9

219. Lalouschek W, Endler G, Schillinger M, Hsieh K, Lang W, Cheng S, Bauer P, Wagner O, Mannhalter C. Candidate genetic risk factors of stroke: results of a multilocus genotyping assay // Clin Chem. - 2007. - 53. - Pp. 600-605

220. Lalouschek W., Schillinger M., Hsieh K., Endler G., Greisenegger S., Marculescu R., Lang W., Wagner O., Cheng S., Mannhalter C. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events //Clin. Chem. Lab. Med. - 2006. - 44. - Pp. 918-923

221. Lambertsen KL, Gregersen R, Meldgaard M, Clausen BH, Heibшl EK, Ladeby R, Knudsen J, Frandsen A, Owens T, Finsen B. A role for interferon-gamma in focal cerebral ischemia in mice // J Neuropathol Exp Neurol. - 2004. - Sep;63(9). - Pp. 942-55

222. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response // FASEB J. - 2004. - May;18(7). - Pp. 816-27

223. Le Beau, M. M., Lemons, R. S., Espinosa 3rd, R., Larson, R. A., Arai, N., & Rowley, J. D. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q) // Blood. - 1989. - 73. - Pp. 647-650

224. Leppala J. M. et al. Different risk factors for different stroke subtypes // Stroke. - 1999. - Vol. 30. - Pp. 2535 - 2540

225. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta // Annu Rev Immunol. - 1998. - V.16. - Рp.137-61

226. Leung T. W, Kwon S. U, Wong K. S. Management of patients with symptomatic intracranial atherosclerosis // Int J Stroke. - 2006. - Vol. 1. - № 1. - Pp. 20 - 25

227. Liao Y.C., Lin H.F., Guo Y.C., Yu M.L., Liu C.K., Juo S.H. Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis // BMC Med Genet. - 2010. - Jun 12;11. - P. 93

228. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes // Circulation. - 2001. - Jul 17;104(3). - Pp. 365-72

229. Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis // Circulation. - 2002. - 105. - Pp. 1135-1143

230. Ligers A., Xu C., Saarinen S., Hillert J., and Olerup O., The CTLA-4 gene is associated with multiple sclerosis // J Neuroimmunol. - 1999. - 97(1-2). - Pp. 182-90

231. Linde R., Laursen H., Hansen A.J. Is Calcium Accumulation Post-Injury an Indicator of Cell Damage // Mechanisms of Secondary Brain Gamage in Cerebral Ischemia and Trauma. Springer Wien NY Acta Neurochir. - 1996. - 66. - Pp. 15-20

232. Lin H., Rathmell J.C., Gray G.S., Thompson C.B., Leiden J.M., Alegre M.L. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28 //J Exp Med. - 1998. - Jul 6;188(1). - Pp. 199-204

233. Li N., He Z., Xu J., Liu F., Deng S., Zhang H. Association of PDE4D and IL-1 gene polymorphism with ischemic stroke in a Han Chinese population // Brain Res Bull. - 2010. - Jan 15;81(1). - Pp. 38-42

234. Lin R.T., Chen C.H., Tsai P.C., Ho B.L., Juo S.H., Lin H.F. Sex-specific effect of matrix metalloproteinase-9 functional promoter polymorphism on carotid artery stiffness // Atherosclerosis. - 2012. - Aug;223(2). - Pp. 416-20

235. Lio D, Marino V, Serauto A, Gioia V, Scola L, Crivello A, Forte GI, Colonna-Romano G, Candore G, Caruso C. Genotype frequencies of the +874T-->A single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis // Eur J Immunogenet. - 2002. - Oct;29(5). - Pp. 371-4

236. Liu H., Maurice D.H. Phosphorylation meditated activation and translocation of the cyclic AMP specific phosphodiesterase PDE4D3 by cyclic AMP dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting // J. Biol. Chem. - 1999. - V. 274. № 15. - Pp. 10557-10565

237. Liu Y, Herrington D, Burdon KP, Langefeld CD, Rich SS, Bowden DW, Freedman BI, Wagenknecht LE. A functional polymorphism in the lymphotoxin-alpha gene is associated with carotid artery wall thickness: the Diabetes Heart Study // Eur J Cardiovasc Prev Rehabil. - 2006. - Aug;13(4). - Pp. 655-7

238. Lo J. C.; Wang, Y.; Tumanov, A. V. et al. Lymphotoxin beta receptor-dependent control of lipid homeostasis // Science. - 2007. - 316. - Pp. 285-288

239. Lohmussaar E., Gschwendtner A., Mueller J. C. ALOX5AP gene and PDE4D gene in a central European population of stroke patients // Stroke. - 2005. - 36. - Pp. 731--736

240. Lonneke M. L. De Lau1, Frank W. G. Leebeek, Moniek P. M. De Maat, Peter J. Koudstaal, Diederik W. J. Dippel. Reviews: A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke // Int J Stroke. - 2010. - Oct;5(5). - Pp. 385-94

241. Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska-Zardzewialy A, Szelagowska D, Windyga J, Schrцder W, Herrmann FH, Jedrzejowska H. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke // Clin Appl Thromb Hemost. - 2001. - 7. - Pp. 346-350

242. Loppnow H., Zhang L., Buerke M., Lautenschlдger M., Chen L., Frister A., Schlitt A., Luther T., Song N., Hofmann B., Rose-John S., Silber R.E., Mьller-Werdan U., Werdan K. Statins potently reduce the cytokine-mediated IL-6 release in SMC // MNC cocultures. J Cell Mol Med. - 2010. - 15

243. Lovett-Racke, A.E., Smith, M.E., Arredondo, L.R., Bittner, P.S., Ratts, R.B., Shive, C.L., Forsthuber, T.G. & Racke, M.K. Developmentally regulated gene expression of Th2 cytokines in the brain // Brain Research. - 2000. - 870. - P.27

244. Lцvkvist H, Smith JG, Luthman H, Hцglund P, Norrving B, Kristoffersson U, Jцnsson AC, Lindgren AG. Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region // Eur J Hum Genet. - 2008. - Sep;16(9). - Pp. 1117-25

245. Lusis A.J. Atherosclerosis // Nature. - 2000. - V. 407. - №68. - Pp. 233-241

246. Lussier Cacan S., Bolduc A., Xhignesse M. et al. Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype // Arterioscl. Thromb. Vasc. Biol. -- 2002. -- 22. -- Pp. 824-831

247. Lvovs D., Favorova O.O., Favorov A.V. A Polygenic Approach to the Study ?of Polygenic Diseases // Acta Naturae. - 2012. - Jul;4(3). - Pp. 59-71

248. Macko RF, Ameriso SF, Gruber A, Griffin JH, Fernandez JA, Barndt R, Quismorio FP Jr, Weiner JM, Fisher M. Impairments of the protein C system and fibrinolysis in infection-associated stroke // Stroke. - 1996. - Nov;27(11). - Pp. 2005-11

249. Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, Sturm J, Scott R, Whyte S, Attia J. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding // J Stroke Cerebrovasc Dis. - 2011. - Mar-Apr;20(2). - Pp. 134-44

...